{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Raza A"],"funding":["NCI NIH HHS"],"pagination":["175-82"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5594745"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["86(3)"],"pubmed_abstract":["<h4>Background</h4>Paroxysmal nocturnal hemoglobinuria (PNH), a rare clonal hematopoietic stem cell disorder, is characterized by chronic, uncontrolled complement activation leading to intravascular hemolysis and an inflammatory prothrombotic state. The EXPLORE study aimed to determine the prevalence of undiagnosed PNH in patients with aplastic anemia (AA), myelodysplastic syndrome (MDS), and/or other bone marrow failure (BMF) syndromes and the effect of PNH clone size on hemolysis.<h4>Methods</h4>Patients, selected from medical office chart reviews, had blood samples collected for hematologic panel testing and for flow cytometry detection of PNH clones.<h4>Results</h4>Granulocyte PNH clones ≥ 1% were detected in 199 of all 5,398 patients (3.7%), 93 of 503 AA patients (18.5%), 50 of 4,401 "],"journal":["Cytometry. Part B, Clinical cytometry"],"pubmed_title":["A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure."],"pmcid":["PMC5594745"],"funding_grant_id":["P30 CA016672"],"pubmed_authors":["Illingworth A","Galili N","Raza A","Rastogi A","Bubis J","Castro-Malaspina H","Jawde RA","Ravandi F","Lim SH","Weitz I"],"additional_accession":[]},"is_claimable":false,"name":"A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.","description":"<h4>Background</h4>Paroxysmal nocturnal hemoglobinuria (PNH), a rare clonal hematopoietic stem cell disorder, is characterized by chronic, uncontrolled complement activation leading to intravascular hemolysis and an inflammatory prothrombotic state. The EXPLORE study aimed to determine the prevalence of undiagnosed PNH in patients with aplastic anemia (AA), myelodysplastic syndrome (MDS), and/or other bone marrow failure (BMF) syndromes and the effect of PNH clone size on hemolysis.<h4>Methods</h4>Patients, selected from medical office chart reviews, had blood samples collected for hematologic panel testing and for flow cytometry detection of PNH clones.<h4>Results</h4>Granulocyte PNH clones ≥ 1% were detected in 199 of all 5,398 patients (3.7%), 93 of 503 AA patients (18.5%), 50 of 4,401 ","dates":{"release":"2014-01-01T00:00:00Z","publication":"2014 May","modification":"2025-05-18T12:52:42.732Z","creation":"2025-05-18T12:52:42.732Z"},"accession":"S-EPMC5594745","cross_references":{"pubmed":["24227693"],"doi":["10.1002/cyto.b.21139"]}}